ClinicalTrials.govpublic full text
Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease
crohn disease, cdp 870, certolizumab pegol, cimzia ®, crohn's disease, induction, clinical remission, clinical response, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 910713
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.